Skip to main content
null
prnano
  • Menu
  • Articles
    • Case study
    • Communication
    • Editorial
    • Editorial Policies
    • Expression of concern
    • Letters to the Editor
    • Perspective, Opinion, or Discussion
    • Research Article
    • Review
    • Technical Note
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • The Rising Talents List
  • Journal Policies
  • search

RSS Feed

Enter the URL below into your favorite RSS reader.

https://precisionnanomedicine.com/feed
Research Article
Vol. 4, Issue 1, 2021January 17, 2021 EDT

Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro

Guankui Wang, Hanmant Gaikwad, Mary McCarthy, Mercedes Gonzalez-Juarrero, Yue Li, Michael Armstrong, Nichole Reisdorph, Thomas Morrison, Dmitri Simberg,
ace2vero e6in vitroreplicationcovid-19virusniclosamidelipidnanoparticlesars-cov-2
Copyright Logoccby-nc-sa-4.0 • https://doi.org/10.33218/001c.18813
prnano
Wang, Guankui, Hanmant Gaikwad, Mary McCarthy, Mercedes Gonzalez-Juarrero, Yue Li, Michael Armstrong, Nichole Reisdorph, Thomas Morrison, and Dmitri Simberg. 2021. “Lipid Nanoparticle Formulation of Niclosamide (Nano NCM) Effectively Inhibits SARS-CoV-2 Replication in Vitro.” Precision Nanomedicine 4 (1): 724–37. https:/​/​doi.org/​10.33218/​001c.18813.
Save article as...▾

View more stats

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Powered by Scholastica, the modern academic journal management system